Publications
Detailed Information
The clinical use of staging bone scan in patients with breast carcinoma: reevaluation by the 2003 American Joint Committee on Cancer staging system
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Jeong Eon | - |
dc.contributor.author | Park, Sung-Shin | - |
dc.contributor.author | Han, Wonshik | - |
dc.contributor.author | Kim, Seok Won | - |
dc.contributor.author | Shin, Hyuk Jai | - |
dc.contributor.author | Choe, Kuk Jin | - |
dc.contributor.author | Oh, Seung Keun | - |
dc.contributor.author | Youn, Yeo-Kyu | - |
dc.contributor.author | Noh, Dong-Young | - |
dc.contributor.author | Kim, Sung-Won | - |
dc.date.accessioned | 2009-11-26T04:26:47Z | - |
dc.date.available | 2009-11-26T04:26:47Z | - |
dc.date.issued | 2005-06-22 | - |
dc.identifier.citation | Cancer. 2005 Aug 1;104(3):499-503 | en |
dc.identifier.issn | 0008-543X (Print) | - |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15968691 | - |
dc.identifier.uri | https://hdl.handle.net/10371/15800 | - |
dc.description.abstract | BACKGROUND: Using the new 2003 American Joint Committee on Cancer (AJCC) staging system, the authors evaluated the usefulness of the staging bone scan in patients with primary breast carcinoma. METHODS: The authors examined 1939 patients with primary breast carcinoma for staging bone scan who were treated at a single institution. Pathologic stage was assigned retrospectively according to the 1988 and the 2003 AJCC staging systems. RESULTS: Bone metastasis rates were 0.7% (4 of 586) for patients with Stage I disease, 0.7% (5 of 699) for patients with Stage IIA disease, 2.1% (10 of 479) for patients with Stage IIB disease, 4.5% (7 of 154) for patients with Stage IIIA disease, and 10.5% (2 of 19) for patients with Stage IIIB disease according to the 1988 AJCC staging system. The authors found a significant difference in the bone metastasis rate between patients with Stages IIA and IIB disease in the 1988 staging system (P = 0.039). Reevaluating the patients by the 2003 system resulted in significant upstaging, especially for patients with Stage II/III disease. According to the 2003 staging system, bone metastasis rates were 0.7% (4 of 586) for patients with Stage I disease, 0.6% (4 of 648) for patients with Stage IIA disease, 0.6% (2 of 310) for patients with Stage IIB disease, 4.0% (9 of 225) for patients with Stage IIIA disease, 16.7% (2 of 12) for patients with Stage IIIB disease, and 4.4% (7 of 158) for patients with Stage IIIC disease. It was noteworthy that there was a significant difference between Stages IIB and IIIA in the 2003 staging system (P = 0.010). CONCLUSIONS: Stage reclassification using the new AJCC staging system resulted in upstaging of high-risk patients, as well as a significant decrease in the bone metastasis rate in patients with Stage IIB breast carcinoma. Considering the cost-effectiveness of staging bone scan, the data suggested that it was of little value for patients with Stage I and II breast carcinoma, but was highly recommended for patients with worse than Stage III disease by the new 2003 staging system. | en |
dc.language.iso | en | - |
dc.publisher | John Wiley & Sons | en |
dc.subject | Adult | en |
dc.subject | Aged | en |
dc.subject | Aged, 80 and over | en |
dc.subject | Bone Neoplasms/*radionuclide imaging/secondary | en |
dc.subject | Bone and Bones/*radionuclide imaging | en |
dc.subject | Breast Neoplasms/*pathology/*radionuclide imaging/therapy | en |
dc.subject | Female | en |
dc.subject | Humans | en |
dc.subject | Middle Aged | en |
dc.subject | Neoplasm Invasiveness/pathology | en |
dc.subject | Neoplasm Staging/*standards | en |
dc.subject | Predictive Value of Tests | en |
dc.subject | Prospective Studies | en |
dc.subject | Radiopharmaceuticals/diagnostic use | en |
dc.subject | Risk Factors | en |
dc.subject | Survival Rate | en |
dc.title | The clinical use of staging bone scan in patients with breast carcinoma: reevaluation by the 2003 American Joint Committee on Cancer staging system | en |
dc.type | Article | en |
dc.contributor.AlternativeAuthor | 이정언 | - |
dc.contributor.AlternativeAuthor | 박성신 | - |
dc.contributor.AlternativeAuthor | 한원식 | - |
dc.contributor.AlternativeAuthor | 김석원 | - |
dc.contributor.AlternativeAuthor | 신혁재 | - |
dc.contributor.AlternativeAuthor | 최국진 | - |
dc.contributor.AlternativeAuthor | 오승근 | - |
dc.contributor.AlternativeAuthor | 윤여규 | - |
dc.contributor.AlternativeAuthor | 노동영 | - |
dc.contributor.AlternativeAuthor | 김성원 | - |
dc.identifier.doi | 10.1002/cncr.21200 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.